NCT05957575 Investigation of the Muscle Oxygenation in Patients With Post COVID-19 Syndrome Status COMPLETED Phase N/A
NCT05951920 Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine. Status COMPLETED Phase NA
NCT05950295 Intranasal Lavage With Hypochlorous Acid Safely Reduces the Symptoms in the Ambulatory Patient With COVID-19. Status COMPLETED Phase N/A
NCT05947643 Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3) Status COMPLETED Phase PHASE2
NCT05946551 Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial Status TERMINATED Phase PHASE3
NCT05946499 Evaluation of Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease: A Case-Control Study Status COMPLETED Phase N/A
NCT05939622 Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19 Status COMPLETED Phase PHASE4
NCT05938140 Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease Status UNKNOWN Phase PHASE4
NCT05935800 The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05935566 Impact of a History of Tonsillectomy or Adenoidectomy on the Severity of COVID-19 : AMYVID Study Status WITHDRAWN Phase N/A
NCT05934279 Developing an Effective Intervention to Address Post-Corona-Virus-Disease-2019 Balance Disorders, Weakness and Muscle Fatigue in Individuals Aged 65+ Status UNKNOWN Phase NA
NCT05933512 A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines Status UNKNOWN Phase PHASE2
NCT05933278 Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine Status COMPLETED Phase PHASE2
NCT05930002 Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial Status COMPLETED Phase NA
NCT05928468 The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002 Status UNKNOWN Phase EARLY_PHASE1